topSkip to main content

Menu, Secondary

Menu Trigger

Menu

New York's Leading Public Research Universities on the Forefront of Education and Innovation

New York’s leading public research universities are on the forefront of education and scientific innovation.


Only sixty-five years young, Stony Brook University is recognized as one of the nation’s top research universities, serving as a powerful engine for economic development, technological innovation and clinical care. SBU is not only transforming lives by revolutionizing cancer prognosis and advancing life-saving technologies for cardiac patients but also by offering a world-class education to students from all socio-economic backgrounds, providing them unmatched social and economic mobility.

The University at Buffalo was recognized as a research powerhouse back in 1989, when it became the first public university in New York invited to join the AAU, and its impact has only grown over the years. From developing new ways to treat memory loss in Alzheimer’s to pioneering minimally invasive surgical techniques, UB is making discoveries that lead to longer, healthier lives.

Learn more about the amazing work happening every day at New York's flagship public research universities:

Researchers at the University at Buffalo are investigating the use of shear-thinning hydrogels (STH) for stem cell therapy to treat neurological diseases like multiple sclerosis (MS).
A recent study conducted by Stony Brook University researchers looked at the reviews of 20 hotels in Chicago, trying to distinguish between the experiences shared by humans on TripAdvisor and those generated by OpenAI’s ChatGPT.
Research led by Stony Brook University has revealed that the smallest microplastic (MP) particles in ocean waters are not detected by standard net tow surveys.
New findings by University at Buffalo researchers reveal that RNA editing may play a larger role in human biology and in the development of human disease than has generally been understood.
A University at Buffalo researcher who is a leading expert on retinopathy of prematurity (ROP) has published a study that could change the standard of care for the condition.